Dan Lemaitre
CIK 1478479 · last filed 2026-01-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
2
Total Filings
38
Lifetime Open-Market Net
-$8.65M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GMED | Director | 0 | $80.39 | $0 | -$8.75M | 22 | 2026-01-23 |
| ENDOLOGIX INC /DE/ (ELGX) Delisted | Director | 54,097 | — | — | $99.8K | 14 | 2019-10-01 |
Recent Filings · Page 2 of 4
38 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-01-31 | GMED | Grant (A) | — | $0 | EDGAR |
| 2021-03-11 | GMED | Mixed | — | -$787.5K | EDGAR |
| 2021-01-19 | GMED | Grant (A) | — | $0 | EDGAR |
| 2020-09-17 | — | Sell (S) | −51,844 | -$2.6K | |
| 2020-08-19 | — | Sell (S) | −2,253 | -$190 | |
| 2020-01-24 | GMED | Grant (A) | — | $0 | EDGAR |
| 2019-10-01 | ENDOLOGIX INC /DE/ (ELGX) Delisted | Mixed | — | $0 | EDGAR |
| 2019-09-12 | ENDOLOGIX INC /DE/ (ELGX) Delisted | Grant (A) | +20,990 | $0 | EDGAR |
| 2019-08-06 | ENDOLOGIX INC /DE/ (ELGX) Delisted | Grant (A) | +13,494 | $0 | EDGAR |
| 2019-02-11 | GMED | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.